As of Apr 24
| -0.01 / -0.57%|
The 2 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 4.96, with a high estimate of 5.92 and a low estimate of 3.99. The median estimate represents a +183.33% increase from the last price of 1.75.
The current consensus among 2 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.